ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE4
A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab
- Status
- TERMINATED
- Phase
- PHASE2
Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nivolumab With Epstein Barr Virus Specific T Cells (EBVSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2